Establishment of a Tumor Bank for Blood Samples

NCT01763125 · tracked via the Priya Life Science Belgium tracker

Sponsor

Medical University of Vienna

Phase

Observational

Started

2003-11

Last updated

2023-03-23

Condition(s) studied

Ovarian NeoplasmsBreast NeoplasmsColorectal NeoplasmsNeoplasms of the Female GenitaliaLung NeoplasmsEndocrine Gland Neoplasms

Investigational drug(s) / intervention(s)

Blood collection

Blood collection: Blood sample is collected during routine blood collection by a medical doctor. No more than 60ml (max.) at one timepoint.

Study summary

Establishment of a tumor bank, consisting of blood samples of tumor patients and healthy people as controls. The blood samples will be collected systematically together with the corresponding clinical data. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tumor bank.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Accepted

Inclusion Criteria: * Male/Female * Age 18 to 90 years max. * Just one current known malignant disease or * Just one current inflammatory disease Exclusion Criteria: * Inflammatory disease and malignant disease * multiple malignancies * multiple diseases * underage

Primary outcome measure(s)

Establishment of blood/tissue bank consisting of oncological samples from cancer patients and benign and healthy controls. — 14 years

Trial sites (6)

Facility	City	Region	Status
Innsbruck Medical University	Innsbruck	Austria	Completed
University Hospitals Leuven - Department of Obstetrics and Gynaecology	Leuven	Belgium	Completed
Charité University - Campus Virchow Chlinic	Berlin	Germany	Recruiting
University Medical Center Freiburg	Freiburg im Breisgau	Germany	Completed
University Clinic of Ruhr University Bochum	Herne	Germany	Completed
European Institute of Oncology, Division of Gynecologic Oncology, Unit of Preventive Gynecology	Milan	Italy	Withdrawn

More Medical University of Vienna trials in Belgium

CMR-AI and Outcomes in AS Active, not recruiting

A Prospective Randomized Trial of ECP in Subclinical AMR Recruiting

Establishment of a Tumor Bank for Tissue Samples Recruiting

Other trials for the same condition

A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer Active, not recruiting

A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy Active, not recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy Recruiting

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021) Recruiting

A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT01763125 on ClinicalTrials.gov ↗ ← All trials in Belgium